Disease-modifying antirheumatic drugs : overview

Kevin D. Pile; Garry G. Graham; Stephen M. Mahler

doi:10.1007/978-3-7643-8550-7_48

Disease-modifying antirheumatic drugs : overview

Kevin D. Pile, Garry G. Graham, Stephen M. Mahler

Western Sydney University

Research output: Chapter in Book / Conference Paper › Chapter

Abstract

Disease-modifying anti-rheumatic drugs (DMARDs) are drugs which decrease the inflammation, slow the damage to joints, and decrease the systemic effects of rheumatoid arthritis and are used or investigated for other inflammatory diseases. There are three major groups: conventional synthetic DMARDs (csDMARDs), targeted synthetic DMARDs (tsDMARDs), and biological DMARDs (bDMARDs).

Original language	English
Title of host publication	Compendium of Inflammatory Diseases
Editors	Michael J. Parnham
Place of Publication	Switzerland
Publisher	Springer
Pages	464-475
Number of pages	12
ISBN (Electronic)	9783764385507
ISBN (Print)	9783764385309
DOIs	https://doi.org/10.1007/978-3-7643-8550-7_48
Publication status	Published - 2016

Keywords

antirheumatic agents

Access to Document

10.1007/978-3-7643-8550-7_48

Cite this

@inbook{75fc9df027fe44769f40066c538326d6,

title = "Disease-modifying antirheumatic drugs : overview",

abstract = "Disease-modifying anti-rheumatic drugs (DMARDs) are drugs which decrease the inflammation, slow the damage to joints, and decrease the systemic effects of rheumatoid arthritis and are used or investigated for other inflammatory diseases. There are three major groups: conventional synthetic DMARDs (csDMARDs), targeted synthetic DMARDs (tsDMARDs), and biological DMARDs (bDMARDs).",

keywords = "antirheumatic agents",

author = "Pile, {Kevin D.} and Graham, {Garry G.} and Mahler, {Stephen M.}",

year = "2016",

doi = "10.1007/978-3-7643-8550-7_48",

language = "English",

isbn = "9783764385309",

pages = "464--475",

editor = "Parnham, {Michael J.}",

booktitle = "Compendium of Inflammatory Diseases",

publisher = "Springer",

}

TY - CHAP

T1 - Disease-modifying antirheumatic drugs : overview

AU - Pile, Kevin D.

AU - Graham, Garry G.

AU - Mahler, Stephen M.

PY - 2016

Y1 - 2016

N2 - Disease-modifying anti-rheumatic drugs (DMARDs) are drugs which decrease the inflammation, slow the damage to joints, and decrease the systemic effects of rheumatoid arthritis and are used or investigated for other inflammatory diseases. There are three major groups: conventional synthetic DMARDs (csDMARDs), targeted synthetic DMARDs (tsDMARDs), and biological DMARDs (bDMARDs).

AB - Disease-modifying anti-rheumatic drugs (DMARDs) are drugs which decrease the inflammation, slow the damage to joints, and decrease the systemic effects of rheumatoid arthritis and are used or investigated for other inflammatory diseases. There are three major groups: conventional synthetic DMARDs (csDMARDs), targeted synthetic DMARDs (tsDMARDs), and biological DMARDs (bDMARDs).

KW - antirheumatic agents

UR - http://handle.westernsydney.edu.au:8081/1959.7/uws:40021

U2 - 10.1007/978-3-7643-8550-7_48

DO - 10.1007/978-3-7643-8550-7_48

M3 - Chapter

SN - 9783764385309

SP - 464

EP - 475

BT - Compendium of Inflammatory Diseases

A2 - Parnham, Michael J.

PB - Springer

CY - Switzerland

ER -

Disease-modifying antirheumatic drugs : overview

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this